Treatment of Dyslipidemia in Patients with Renal Insufficiency and End-Stage Renal Disease-Reference-Cited by-同舟云学术

Treatment of Dyslipidemia in Patients with Renal Insufficiency and End-Stage Renal Disease

Published:2011 Issue: Volume: Page:205-218
ISSN:
Container-title:Hyperlipidemia in Primary Care
language:
Short-container-title:

Author:

Sorrentino Matthew J.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-60327-502-6_12.pdf

Reference52 articles.

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1–266.

2. Shulman NB, Ford CE, Hall WD, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension. 1989;13(5 Suppl):I80–93.

3. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5):853–906.

4. Iseki K, Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int. 2002;61(5):1887–93.

5. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42(5):1050–65.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Hypolipidemic Activity of New 6,6-Disubstituted 3-R-6,7-Dihydro-2H -[1,2,4]triazino[2,3-c ]quinazolin-2-Ones;Journal of Heterocyclic Chemistry;2017-11-22